Stock PPLPHARMA PIRAMAL PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Piramal Pharma Limited

Equities

PPLPHARMA

INE0DK501011

Pharmaceuticals

Market Closed - NSE India S.E.
Other stock markets
 07:43:53 2024-05-06 am EDT 		5-day change 1st Jan Change
156 INR +3.28% Intraday chart for Piramal Pharma Limited +8.86% +12.35%
Apr. 27 Piramal Pharma Limited Receives Assessment Orders from the Office of the Navi Mumbai Municipal Corporation, Cess Department CI
Apr. 19 Piramal Pharma Limited Receives Order from the Regional Provident Fund Commissioner, Thane South, Levying Damages of INR 1,120,932 Under Bombay Provincial Municipal Corporation (Cess on Entry of Goods) Rules, 1996 CI

Business Summary

Piramal Pharma Limited is an India-based pharmaceutical company, which offers a portfolio of differentiated pharma products across a domestic and global distribution network. The Company has approximately 17 global facilities and a global distribution network in over 100 countries. The Company's subsidiaries include Piramal Pharma Solutions (PPS), an integrated contract development and manufacturing organization; Piramal Critical Care (PCC), a complex hospital generics business, and the India consumer healthcare business selling over-the-counter products. PPS offers end-to-end development and manufacturing solutions through a globally integrated network of facilities across the drug life cycle to generic companies. PCC's complex hospital product portfolio includes inhalation anesthetics, intrathecal therapies for spasticity and pain management, injectable pain, anesthetics, injectable anti-infectives, and other therapies.

Number of employees: 6,295

Sales per Business

INR in Million2022Weight2023Weight Delta
Global Pharma
87.0 %
22,356 72.2 % 61,581 87.0 % +175.45%
Over the Counter Products
11.6 %
7,420 24.0 % 8,188 11.6 % +10.35%
Distribution Fees
0.8 %
- - 556 0.8 % -
Scrap
0.5 %
- - 323 0.5 % -
Others
0.2 %
- - 169 0.2 % -

Sales per region

INR in Million2022Weight2023Weight Delta
International
79.6 %
-- 56,371 79.6 % -
India
20.4 %
30,950 100.0 % 14,445 20.4 % -53.33%

Managers

Managers TitleAgeSince
Peter DeYoung CEO
 Chief Executive Officer 46 20-03-03
Vivek Valsaraj PSD
 President 51 20-06-09
Vinay Agrawal COO
 Chief Operating Officer 60 20-04-04
Gagan Borana IRC
 Investor Relations Contact - -
Prasanth M. S. SAM
 Sales & Marketing 51 20-06-09
Vikram Duggal HRO
 Human Resources Officer 50 20-01-07
Sameer Penkar SAM
 Sales & Marketing - 20-06-09
Tanya Smiley DCosta SEC
 Corporate Secretary - 20-03-03
Rashida Najmi PRN
 Corporate Officer/Principal 58 -

Members of the board

Members of the board TitleAgeSince
Nandini Ajay Piramal CHM
 Chairman 43 21-01-03
Neeraj Bharadwaj BRD
 Director/Board Member 55 -
Subramanian V. Ramadorai BRD
 Director/Board Member 76 21-02-08
Sridhar Ananta Bhanu Gorthi BRD
 Director/Board Member 51 22-03-29
Vibha Paul Rishi BRD
 Director/Board Member 63 22-09-28
Jairaj Manohar Purandare BRD
 Director/Board Member 64 21-02-08
Peter DeYoung CEO
 Chief Executive Officer 46 20-03-03
Vivek Valsaraj PSD
 President 51 20-06-09
Peter Stevenson BRD
 Director/Board Member - 22-03-29
Nathalie Leitch BRD
 Director/Board Member - 22-05-23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,322,948,130 351,369,835 ( 26.56 %) 4,997,378 ( 0.3777 %) 26.56 %

Shareholders

NameEquities%Valuation
Ajay Gopikisan Piramal
27.70 %
366,431,784 27.70 % 566 M ₹
The Carlyle Group LP (Global Credit)
18.47 %
244,374,445 18.47 % 378 M ₹
East Bridge Capital Management L.P.
5.191 %
68,680,593 5.191 % 106 M ₹
HDFC Asset Management Co. Ltd. (Invt Mgmt)
5.009 %
66,261,821 5.009 % 102 M ₹
V3 Designs LLP
3.330 %
44,054,349 3.330 % 68 M ₹
The Caisse de dépôt et placement du Québec
3.274 %
43,309,424 3.274 % 67 M ₹
Prl Realtors LLP
3.080 %
40,752,489 3.080 % 63 M ₹
PIRAMAL ENTERPRISES LIMITED
0.8190 %
10,834,462 0.8190 % 17 M ₹
Alpex Holdings Pvt Ltd.
0.6913 %
9,145,443 0.6913 % 14 M ₹
Canara Robeco Asset Management Co. Ltd.
0.5669 %
7,500,000 0.5669 % 12 M ₹

Company contact information

Piramal Pharma Ltd.

507, Skyline Wealth Space, 5th Floor C2 Wing, Skyline Oasis Complex

400086, Mumbai

+91 22 3802 3000

http://www.piramal.com/businesses/piramal-pharma/
address Piramal Pharma Limited(PPLPHARMA)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Piramal Pharma Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
156 INR
Average target price
168.4 INR
Spread / Average Target
+7.95%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
PIRAMAL PHARMA LIMITED Stock Piramal Pharma Limited
+12.35% 2.4B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+31.52% 662B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.96% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.21% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.02% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.01% 289B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 234B
NOVARTIS AG Stock Novartis AG
+3.81% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-10.63% 194B
AMGEN INC. Stock Amgen Inc.
+3.98% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. PPLPHARMA Stock
  4. Company Piramal Pharma Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW